About The Medical Condition Drug Evaluation, FDA Phase 4
Find the definition of the medical term Drug Evaluation, FDA Phase 4. Drug Evaluation, FDA Phase 4 defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
Drug Evaluation, FDA Phase 4
| Drug Evaluation, FDA Phase 4 Medical Condition |
|---|
What's The Definition Of The Medical Condition Drug Evaluation, FDA Phase 4?
Planned post-marketing studies of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques that have been approved for general sale. These studies are often conducted to obtain additional data about the safety and efficacy of a product. This concept includes phase IV studies conducted in both the U.S. and in other countries.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Reductase, NADH-Ferrihemoglobin ‐ An erythrocyte enzyme which catalyzes the reduction of methemoglobin…
- Middle Brachial Plexus Neuropathy ‐ Diseases of the cervical (and first thoracic) roots, nerve trunks,…
- Rejection (Psychology) ‐ Non-acceptance, negative attitudes, hostility or excessive criticism…
- Implantable Infusion Pumps ‐ Implanted fluid propulsion systems with self-contained power…
- Omega-Conotoxin ‐ A family of structurally related neurotoxic peptides from mollusk…
- Computings, Mathematic ‐ Computer-assisted interpretation and analysis of various mathematical…
- Fructose 1-Phosphate Aldolase ‐ An enzyme of the lyase class that catalyzes the cleavage of fructose…
- Ictalurus punctatus ‐ A family of North American freshwater CATFISHES. It consists…
- Polyacid-Modified Composite Resins ‐ Composite materials composed of an ion-leachable glass embedded…
- Dylox ‐ A organochlorophosphate cholinesterase inhibitor that is used…